Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Micro Labs Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (165)
Prescription medicine registration (18)
Cancellation by sponsor (2)

Date

2025 (29)
2024 (16)
2023 (36)
2022 (14)
2021 (6)
2020 (4)
2019 (5)
2018 (20)
2017 (39)
2016 (16)

Search

Sponsor content

185 result(s) found, displaying 131 to 140

AMCLAVOX DUO FORTE 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289508)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMCLAVOX DUO FORTE 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
AMOXYCLAV MLabs 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets blister pack (288123)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV MLabs 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets blister pack.
AMOXYCLAV B&B 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289514)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV B&B 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
AMOXYCLAV MLabs 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets blister pack (288122)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV MLabs 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets blister pack.
COCLAVMOX 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289509)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for COCLAVMOX 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289515)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
AMOXYCLAV MLabs 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289513)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV MLabs 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
AMCLAVOX DUO 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289507)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMCLAVOX DUO 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
COCLAVMOX 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack (289510)

7 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for COCLAVMOX 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack.
SODIUM NITROPRUSSIDE, SODIUM NITROPRUSSIDE B&B, SODIUM NITROPRUSSIDE MEDSURGE, SODIUM NITROPRUSSIDE MICRO MEDICS (Micro Labs Pty Ltd)

13 February 2020

Prescription medicine registration

Active ingredients: sodium nitroprusside.

Pages

First page
Previous page
…
Page 10
Page 11
Page 12
Page 13
Current page 14
Page 15
Page 16
Page 17
Page 18
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.